title: Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
authors.forename: Michele
authors.initials: M
authors.lastname: Pohlen
authors.forename: Bülent
authors.initials: B
authors.lastname: Sargin
authors.forename: Stefan
authors.initials: S
authors.lastname: Zicholl
authors.forename: Guido
authors.initials: G
authors.lastname: Bisping
authors.forename: Carsten
authors.initials: C
authors.lastname: Müller-Tidow
authors.forename: Wolfgang E
authors.initials: WE
authors.lastname: Berdel
authors.forename: Rolf
authors.initials: R
authors.lastname: Mesters
authors.forename: Steffen
authors.initials: S
authors.lastname: Koschmieder
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008875:Middle Aged; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012074:Remission Induction; D000069283:Rituximab; D013926:Thrombopoietin / Q000008:administration & dosage*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007155:Immunologic Factors; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D000069283:Rituximab; D013926:Thrombopoietin; C488777:romiplostim